BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 21551152)

  • 1. Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter-Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction.
    Hillmann HAK; Hohmann S; Mueller-Leisse J; Zormpas C; Eiringhaus J; Bauersachs J; Veltmann C; Duncker D
    Sensors (Basel); 2021 Nov; 21(23):. PubMed ID: 34883802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of GLP-1 receptor agonists in hospitalised patients: An untapped potential.
    Mustafa OG; Whyte MB
    Diabetes Metab Res Rev; 2019 Nov; 35(8):e3191. PubMed ID: 31141838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is ischemia the most powerful indicator of myocardial viability?
    Shirani J
    Curr Cardiol Rep; 2013 May; 15(5):354. PubMed ID: 23512623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine stress echocardiography and the effect of revascularization on outcome in diabetic and non-diabetic patients with chronic ischaemic left ventricular dysfunction.
    Cortigiani L; Sicari R; Desideri A; Bigi R; Bovenzi F; Picano E;
    Eur J Heart Fail; 2007 Oct; 9(10):1038-43. PubMed ID: 17707132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction.
    Rambaldi R; Bax JJ; Rizzello V; Biagini E; Valkema R; Roelandt JR; Poldermans D
    Coron Artery Dis; 2005 May; 16(3):141-5. PubMed ID: 15818082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of improvement in left ventricular ejection fraction on long-term survival in revascularized patients with ischaemic left ventricular systolic dysfunction.
    Joshi K; Alam I; Ruden E; Gradus-Pizlo I; Mahenthiran J; Kamalesh M; Feigenbaum H; Sawada S
    Eur J Echocardiogr; 2011 Jun; 12(6):454-60. PubMed ID: 21551152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Ischemia As a Prognostic Mandate for Coronary Revascularization in Asymptomatic Patients: How Much Is Enough?
    Shabbir A; Fan L; Fraser G; Cassar MP; Swinburn J
    Crit Pathw Cardiol; 2019 Jun; 18(2):98-101. PubMed ID: 31094737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain imaging - from Scandinavian research to global deployment.
    Edvardsen T; Sarvari SI; Haugaa KH
    Scand Cardiovasc J; 2016; 50(5-6):266-275. PubMed ID: 27650726
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.